Aspire Biopharma Holdings Inc.

08/18/2025 | Press release | Distributed by Public on 08/18/2025 06:49

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial[...]

Aspire Biopharma Holdings Inc. published this content on August 18, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 18, 2025 at 12:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]